SCHEMBL28744862

SCHEMBL28744862

Cc1cnc(Cl)nc1Oc1ccc(OC(N)=O)cc1

nearest known ligand 0.43

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.43
▸ CASP6 P55212 1/20 0.43
▸ PIN1 Q13526 9/20 0.40
▸ RAB9A P51151 1/20 0.38
▸ LIPE Q05469 3/20 0.36
▸ BCHE P06276 1/20 0.36
▸ CYP1A2 P05177 1/20 0.35
▸ F2 P00734 1/20 0.35
▸ F10 P00742 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ KIF11 P52732 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28744834 0.86 POLB (0.45) POLBCASP6PIN1RAB9ALIPE
SCHEMBL28745142 0.83 POLB (0.43) POLBCASP6PIN1RAB9ALIPE
SCHEMBL28744846 0.80 KIF11 (0.43) POLBCASP6PIN1LIPESMN1; SMN2
SCHEMBL29041274 0.77 PIN1 (0.60) POLBCASP6PIN1RAB9ACYP1A2
SCHEMBL28744879 0.74 PLAAT3 (0.45) RAB9ALIPEF2F10SMN1; SMN2
SCHEMBL12813335 0.70 AXL (0.52) POLBCASP6PIN1SMN1; SMN2
SCHEMBL9945481 0.70 PIN1 (0.47) POLBPIN1F10
SCHEMBL28724684 0.69 MEN1 (0.43) RAB9ACYP1A2SMN1; SMN2KIF11
SCHEMBL29255026 0.69 LTA4H (0.53) LIPEBCHESMN1; SMN2
SCHEMBL16670419 0.69 PIN1 (0.52) POLBCASP6PIN1RAB9ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114276331-B 4-aminopiperidine compound and preparation method, pharmaceutical composition and application thereof 中国药科大学 2023-05-23 — — CN disclosed
CN-114276331-A 4-aminopiperidine compound and preparation method, pharmaceutical composition and application thereof 中国药科大学 2022-04-05 — — CN disclosed
Send feedback